Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05924022 · ClinicalTrials.gov registry record · Phase 1

Hyperbaric Oxygen Treatment (HBOT) During Methadone Tapering

A Phase 1 study of Opioid Use Disorder, sponsored by Washington State University.

Active
Registry status
Phase 1
Development phase
36
Enrollment target
1
Study location

NCT05924022 is a Phase 1 study of Opioid Use Disorder that is active but no longer recruiting, run by Washington State University. The registered enrollment target is 36 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05924022, a Phase 1 study of Opioid Use Disorder, is active but no longer recruiting, sponsored by Washington State University.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

The aims of this study are to 1) explore the efficacy of hyperbaric oxygen therapy (HBOT) applied at two different pressures compared to sham treatment in relieving signs and symptoms (both physical and psychological) of opioid withdrawal in human subjects associated with methadone dose reductions; and 2): explore whether HBOT can increase the odds of successful methadone dose reduction in patients who are interested in tapering their opioid dose. The investigators aim to explore, through qualitative methods, individual's experiences with treatment for opioid use disorder (OUD).

Conditions Studied

Opioid Use Disorder

Interventions

  • COMBINATION_PRODUCT Hyperbaric Oxygen Treatment Full
  • COMBINATION_PRODUCT Hyperbaric Oxygen Treatment Sham
  • COMBINATION_PRODUCT Hyperbaric Oxygen Treatment Partial Pressure

Study Locations (1)

Washington

  • Spokane Regional Health District - Spokane

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2023-12-04
Est. Completion 2025-12-30
Phase Phase 1

Sponsor

Washington State University

64 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05924022

The ClinicalTrials.gov registry entry for NCT05924022 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The listed sponsor is Washington State University, which has 64 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 3 interventions - of which Hyperbaric Oxygen Treatment Full is the first listed.

NCT05924022 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT05924022 about?

NCT05924022 is a clinical study titled "Hyperbaric Oxygen Treatment (HBOT) During Methadone Tapering". The aims of this study are to 1) explore the efficacy of hyperbaric oxygen therapy (HBOT) applied at two different pressures compared to sham treatment in relieving signs and symptoms (both physical and psychological) of opioid withdrawal in human subjects associated with methadone dose reductions; ...

What is the current status of trial NCT05924022?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2023-12-04. Estimated completion is 2025-12-30.

What conditions does trial NCT05924022 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT05924022?

The interventions under investigation include: Hyperbaric Oxygen Treatment Full (COMBINATION_PRODUCT), Hyperbaric Oxygen Treatment Sham (COMBINATION_PRODUCT), Hyperbaric Oxygen Treatment Partial Pressure (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT05924022?

This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05924022 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Opioid Use Disorder

All registered trials for this condition

Washington

All trials with a study site in Washington

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.